Keywords |
Page Numbers |
Androgens |
24 |
Association |
80 |
Blood Pressure |
29 |
Breast Cancer |
55 |
Buserelin |
49 |
CABG |
69 |
COVID-19 |
55 |
Cervical cancer |
17 |
Constipation |
11 |
Coping strategies |
55 |
Curcumin |
3 |
DVT |
69 |
Dual-energy X-ray absorptiometry |
3 |
Endoglin |
29 |
Exercise |
69 |
Genitourinary syndrome of menopause |
61 |
GnRH agonist |
49 |
HPV 16 |
17 |
Health promotion lifestyle |
3 |
High-risk pregnancy |
42 |
Homocysteine |
24 |
Human papillomavirus |
17 |
In vitro fertilization |
49 |
Jordan |
17 |
Knowledge |
42 |
L-arginine |
29 |
Laser therapy |
61 |
Letrozole |
75 |
Lipids |
24 |
Maternal serum zinc |
35 |
Menopause |
3 |
Mixed urinary incontinence |
61 |
N-acetylcysteine |
75 |
Perceived stress |
55 |
Persian medicine |
11 |
Physiotherapy |
69 |
Placenta accrete spectrum |
35 |
Placenta previa |
35 |
Platelet-to-lymphocyte ratio |
80 |
Polycystic ovarian syndrome |
75 |
Polycystic ovary syndrome |
24 |
Postmenopausal osteoporosis |
3 |
Practice |
42 |
Pre-pregnancy |
42 |
Preeclampsia |
29 |
Pregnancy |
75, 11 |
Premature rupture of membranes |
80 |
Prevalence |
17 |
Prevention |
69 |
Pulsed radiofrequency treatment |
61 |
Quality of life |
3 |
Real-time PCR |
17 |
Rosa damascena products |
11 |
Spinal metastasis |
55 |
Traditional medicine |
11 |
Transforming Growth Factor-ß1 |
29 |
Triptorelin |
49 |
Vulvovaginal atrophy |
61 |